Cancer Screening Firm Anpac Completes Series A Round
August 19, 2015 — 11:13 CST
This Data Is Locked!
This area is available only to Subscribers.
Sacramento, California-based cancer screening biotech firm Anpac Bio-Medical Science Co., Ltd. has completed series A round of funding from Shanghai Zhangjiang Science & Technology Investment... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
